无载体纳米产物用于最小侵入性癌症治疗
Keita Tanita1, Yoshitaka Koseki1,2, Sanjay Kumar1
1Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, 980-8577, Japan. koseki@tohoku.ac.jp.
Nanoscale
|July 29, 2024
概括
一种新型纳米原药 (NPD) 仅在癌细胞中释放抗癌剂SN-38,增强疗效并减少副作用. 这种创新方法避免了载体和添加剂,以改善癌症治疗.
科学领域:
- 纳米技术 纳米技术
- 在瘤学瘤学.
- 药用化学 医学化学
背景情况:
- 传统的纳米药物往往需要载体和添加剂,导致潜在的副作用.
- 开发具有针对性的有效抗癌药物仍然是一个重大挑战.
研究的目的:
- 开发一种新的纳米原药 (NPD),以提高抗癌效果,并减少副作用.
- 研究一种无载体,无添加剂的药物输送系统,利用自组装的前药物.
主要方法:
- 制造抗癌剂SN-38的同位素纳米产物 (NPD),通过二硫化键连接.
- 评估前药物稳定性,由谷氨触发的选择性药物释放,以及纳米粒子分散稳定性.
- 在动物模型中对抗瘤活性的评估,与临床上使用的 irinotekan 相比.
主要成果:
- 开发的NPD显示出出色的分散稳定性.
- 动物研究显示,与氨酸相比,NPD的抗瘤活性显著更高.
- 由于尺寸效应和二硫化键裂解机制,观察到瘤积累的改善和向药物释放.
结论:
- 开发的无载体,无添加剂的NPD为非侵入性癌症治疗提供了一个有希望的策略.
- 这种方法可以实现向药物释放和增强药理活性.
- 这项研究为设计能够对各种生物触发器作出反应的前药物开辟了新的途径.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


